## NEM: Newmont Corporation - XLB: Basic Materials

### Executive Summary

No thesis match: MRS_20 -0.4% below STRENGTH zone (4.0-10.0%); PEG 2.25 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($83.26)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Why Has Newmont Stock Surged 135%?**
- Source: Trefis | 20251205T193253 | Bullish | Relevance: 100%
- Newmont (NYSE:NEM) stock has surged 135% year-to-date in 2025, primarily driven by a dramatic increase in gold prices due to macroeconomic uncertainty. The company's strategic actions, including divesting non-core assets, cost-cutting, and significant debt reduction, have further amplified these gains. Newmont's strong financial health, with robust revenue growth and operating margins, positions it well for future upside if gold prices remain strong, though it remains exposed to commodity price volatility.

**2. Bull of the Day: Newmont (NEM)**
- Source: Finviz | 20251204T120838 | Bullish | Relevance: 100%
- Newmont (NEM) is highlighted as the Bull of the Day due to its strong performance amid a favorable gold market. The company, a Zacks Rank #1 (Strong Buy), has seen robust quarterly results, exceeding EPS estimates and achieving record Q3 free cash flow of $1.6 billion. This strong cash generation has enabled increased dividends and buybacks, making it an attractive investment.

**3. Newmont Stock (NEM) After December 3, 2025: Record Free Cash Flow, Job Cuts and Insider Selling â€“ Is There Still Upside?**
- Source: ts2.tech | 20251204T010727 | Somewhat-Bullish | Relevance: 100%
- Newmont Corporation (NEM) experienced a standout 2025, with its stock more than doubling in value after achieving record free cash flow, notably $1.6 billion in Q3 2025. The company is undergoing significant restructuring, including job cuts and a CEO transition, following its Newcrest acquisition, all while benefiting from near-record gold prices. Despite a recent insider stock sale and warnings about Q4 free cash flow, analysts generally maintain a bullish outlook, though with modest near-term upside expectations.

**4. Newmont (NYSE: NEM) director trades 2,080 shares under Rule 10b5-1 plan**
- Source: Stock Titan | 20251203T213500 | Somewhat-Bearish | Relevance: 100%
- A director at Newmont Corporation, Bruce R. Brook, reported selling 2,080 shares of Newmont common stock on December 1, 2025, at a price of $92.36 per share. This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on September 3, 2024. Following the sale, the director directly owns 32,709 shares of Newmont common stock.

**5. Newmont (NEM): Reassessing Valuation After Strong Q3 Earnings, Record Gold Prices and Analyst Upgrades**
- Source: Simply Wall Street | 20251203T203406 | Bullish | Relevance: 100%
- Newmont (NEM) is experiencing a resurgence in value due to robust Q3 earnings, record gold prices, share buybacks, and a strong balance sheet, leading to a 117% stock increase this year and a 12.5% undervaluation based on a narrative fair value of $103.42. The company's recent acquisition of Newcrest Mining and ongoing expansion projects are expected to drive long-term revenue growth and cash flow stability. Investors are evaluating whether the market is still underestimating its cash flow power or has already factored in future growth.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-01 | UBS | $125 | $106 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-01 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($2.91M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 12.2% (-1.1%)
- Blackrock Inc.: 11.2% (+3.4%)
- State Street Corpora: 4.5% (-0.3%)
- Geode Capital Manage: 2.4% (+3.9%)
- Van Eck Associates C: 2.2% (-42.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.25 elevated, pricing in significant growth expectations. Forward P/E 11.6x attractive for 23% earnings growth. Quality metrics strong (ROE 23%, ROA 10%, margin 33%). Balance sheet: strong liquidity (2.0x), $1.6B free cash flow. Analyst sentiment positive (1 raises, avg +18%). Insider selling cluster ($2.9M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $116.2B |
| Beta | 0.43 |
| 52W Range | $36.86 - $106.34 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.25 |
| Forward P/E | 11.6 |
| Current P/E | 14.3 |
| YoY Growth | 23.2% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 5.3% to -0.4% (-5.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.4pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 55. OFD pattern: -SUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.41% (CS: 50) | Neutral |
| RSI_14 | 54.7 | Neutral |
| MACD Histogram | 0.27 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.034x | Above |
| vs SMA200 | 1.372x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $89.76
- **Stop Loss:** $83.26 (7.2% risk)
- **Target:** $96.26 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 76
- **Position Value:** $6,821.76
- **Portfolio %:** 6.82%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-19 (Est: $1.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.44 | $1.71 | +18.8% |
| 2025Q2 | $1.16 | $1.43 | +22.9% |
| 2025Q1 | $0.91 | $1.25 | +37.1% |
| 2024Q4 | $1.03 | $1.40 | +35.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*